<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2015-4-54-59</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-208</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>ЭФФЕКТИВНОСТЬ ЛЮДАРТИНА И ЛЕУКОМИЗИНА ПРИ ОСТРОЙ ЭКСПЕРИМЕНТАЛЬНОЙ ГИПЕРЛИПИДЕМИИ, ИНДУЦИРОВАННОЙ ЭТАНОЛОМ</article-title><trans-title-group xml:lang="en"><trans-title>EFFECTS OF LUDARTIN AND LEUKOMISIN ON THE ACUTE HYPERLIPIDEMIA MODEL INDUCED BY ETHANOL</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ратькин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ratkin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кайдаш</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaidash</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Венгеровский</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vengerovsky</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Венгеровский Александр Исаакович – доктор медицинских наук, профессор, зав. кафедрой фармакологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Адекенов</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Adekenov</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чучалин</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Chuchalin</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет, Томск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University, Tomsk</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Международный научно-производственный холдинг «Фитохимия», Караганда</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>International Scientific-Industrial Holding “Phytochemistry”, Karaganda</institution><country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>28</day><month>08</month><year>2015</year></pub-date><volume>14</volume><issue>4</issue><fpage>54</fpage><lpage>59</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ратькин А.В., Кайдаш О.А., Иванов В.В., Венгеровский А.И., Адекенов С.М., Чучалин В.С., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Ратькин А.В., Кайдаш О.А., Иванов В.В., Венгеровский А.И., Адекенов С.М., Чучалин В.С.</copyright-holder><copyright-holder xml:lang="en">Ratkin A.V., Kaidash O.A., Ivanov V.V., Vengerovsky A.I., Adekenov S.M., Chuchalin V.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/208">https://bulletin.ssmu.ru/jour/article/view/208</self-uri><abstract><p>Цель исследования – изучение гиполипидемических свойств сесквитерпеновых лактонов людартина и леукомизина при экспериментальной острой гиперлипидемии, индуцированной этанолом, у крыс.</p><sec><title>Материал и методы</title><p>Материал и методы. Крысам в течение 7 сут вводили в желудок людартин и леукомизин в дозе 10 мг/кг массы тела или препарат сравнения никотиновую кислоту в дозе 25 мг/кг массы тела. Гиперлипидемию у крыс вызывали однократным внутрижелудочным введением этанола в дозе 5 г/кг массы тела. В сыворотке крови хвостовой вены измеряли содержание триацилглицеридов, общего холестерина, холестерина липопротеинов низкой (ЛПНП) и высокой плотности (ЛПВП), свободных жирных кислот. Вычисляли отношение содержания холестерина ЛПВП к количеству холестерина ЛПНП и индекс атерогенности.</p></sec><sec><title>Результаты</title><p>Результаты. Однократное введение этанола повышало в сыворотке крови уровень триацилглицеридов в 1,9 раза, свободных жирных кислот в 3,2 раза, холестерина ЛПНП – на 44% по сравнению с показателями интактных животных, что свидетельствует о развитии острой гиперлипидемии. Содержание в сыворотке общего холестерина, холестерина ЛПВП и индекс атерогенности не изменялись.</p><p>Курсовое введение сесквитерпеновых лактонов людартина и леукомизина на фоне острой гиперлипидемии сопровождалось снижением в сыворотке крови уровня триацилглицеридов на 37,5 и 49,5% соответственно. Никотиновая кислота уменьшала содержание триацилглицеридов на 42,4%. Людартин, леукомизин и никотиновая кислота снижали повышенный уровень свободных жирных кислот в сыворотке крови крыс на 63,4; 41,6 и 67,9% соответственно. Людартин, леукомизин и никотиновая кислота снижали соответственно на 15,8; 20,3 и 17,2% уровень общего холестерина.</p><p>При острой гиперлипидемии людартин и леукомизин снижали уровень холестерина ЛПНП на 23,8–14,8%, никотиновая кислота – на 15,7%. Оба сесквитерпеновых лактона и никотиновая кислота не изменяли содержания холестерина ЛПВП. При курсовом введении людартина и никотиновой кислоты отношение содержания холестерина ЛПВП к количеству холестерина ЛПНП статистически значимо увеличивалось на 32,7 и 22,1% соответственно.</p></sec><sec><title>Заключение</title><p>Заключение. Сесквитерпеновые лактоны людартин и леукомизин обладают гиполипидемическим действием при острой экспериментальной гиперлипидемии, вызванной введением этанола. Лактоны нормализуют многие показатели липидного обмена, что может быть обусловлено разными биохимическими мишенями для этих молекул. Лактоны, как и никотиновая кислота, при модели острой гиперлипидемии снижают в сыворотке крови содержание триацилглицеридов, общего холестерина и холестерина ЛПНП.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: study sesquiterpene lactones ludartin and leukomisin lipid-lowering properties on the model of acute hyperlipidemia induced by ethanol in rats.</p></sec><sec><title>Material and methods</title><p>Material and methods. Rats during 7 days injected into the stomach ludartin and leukomisin in a dose 10 mg/kg or reference drug nicotinic acid in a dose 25 mg/kg. Hyperlipidemia caused by single introduc-tion of ethanol into the stomach in a dose 5 g/kg. In blood serum of tail vein measured the triacylgly-cerols, total cholesterol, high density and low density lipoproteins cholesterol, also the level of free fatty acids. Calculated the ratio of high density lipoproteins cholesterol to the amount of low density lipopro-teins cholesterol and the index of atherogenicity.</p></sec><sec><title>Results</title><p>Results. A single dose of ethanol increased serum level of triacylglycerols in 1.9 times, free fatty acids – in 3.2 times, low density lipoproteins – on 44% in comparison with the intact animals indices. It shows the development of acute hyperlipidemia. Serum total cholesterol, high density lipoproteins cholesterol and the index of atherogenicity were not changed. Course introduction of sesquiterpene lactones ludartin and leukomisin against the background of acute hyperlipidemia was accompanied by a decrease in the serum of triacylglycerols levels respectively by 37.5% and 49.5%. Nicotinic acid lowered the content of triacylglycerols by 42.4%. Ludartin, leukomisin and nicotinic acid reduced the increased level of free fatty acids in the blood serum by 63.4%, 41.6% and 67.9%. Ludartin, leukomisin and nicotinic acid de-creased by 15.8%, 20.3% and 17.2% of total cholesterol in the blood serum. In acute hyperlipidemia ludartin and leukomisin reduced low density lipoproteins cholesterol by 23.8% and 14.8%, respectively, nicotinic acid – by 15.7%. Both of sesquiterpene lactone and nicotinic acid did not modify the content of high density lipoproteins cholesterol. When introduction ludartin and nicotinic acid ratio of high density lipoproteins cholesterol to the amount of low density lipoproteins cholesterol significantly increased by 32.7% and 22.1% respectively.</p></sec><sec><title>Conclusion</title><p>Conclusion. Sesquiterpene lactones ludartin and leukomisin posses hypolipidemic effect in acute experi-mental hyperlipidemia caused by the ethanol introduction. Lactones normalize many indices of lipid me-tabolism, which can be caused by different biochemical targets of these molecules. Lactones, as nicotinic acid, in the model of acute hyperlipidemia decrease in blood serum triacylglycerols, total cholesterol, and low density lipoproteins cholesterol content. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>: экспериментальная гиперлипидемия</kwd><kwd>этанол</kwd><kwd>людартин</kwd><kwd>леукомизин</kwd><kwd>никотиновая кислота</kwd><kwd>липолиз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>experimental hyperlipidemia</kwd><kwd>ethanol</kwd><kwd>ludartin</kwd><kwd>leukomisin</kwd><kwd>nicotinic acid</kwd><kwd>lipolysis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Atherosclerosis – Diet-induce atherosclerosis/hypercholesterolemia in rodent models. Ed. by M.A. Pellizzon. URL: http://www.researchdiets.com/product-literature</mixed-citation><mixed-citation xml:lang="en">Atherosclerosis – Diet-induce atherosclerosis/hyperchole-sterolemia in rodent models. Ed. by M.A. Pellizzon. URL: http://www.researchdiets.com/product-literature</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Laan P.A., Reardon С.А. The unusual suspects: an overview of the minor leucocyte populations in atherosclerosis // J. Lipid Res. 2005. V. 46, № 7. P. 829–838.</mixed-citation><mixed-citation xml:lang="en">Vander Laan P.A., Reardon С.А. The unusual suspects: an overview of the minor leucocyte populations in atherosclerosis. J. Lipid Res., 2005, vol. 46, no. 7, pp. 829–838.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Буеверова Е.Л., Драпкина О.М., Ивашкин В.Т. Атерогенная дислипидемия и печень // Рос. мед. вести. 2008. Т. 13, № 1. С. 17–23.</mixed-citation><mixed-citation xml:lang="en">Bueverova Ye.L., Drapkina O.M., Ivashkin V.T. Aterogennaya dislipidemiya i pechen' [Atherogenous dyslipidemia and liver]. Rossiyskie medicinskie vesti – The Russian Medical Vesti, 2008, vol. 13, no. 1, pp. 17–23 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hansson G.K., Robertson A.-K.L., Soderberg-Naucler C. In-flammation and atherosclerosis // Annu. Rev. Pathol. Mech. Dis. 2006. V. 1, № 2. P. 297–329.</mixed-citation><mixed-citation xml:lang="en">Hansson G.K., Robertson A.-K.L., Soderberg-Naucler C. Inflammation and atherosclerosis. Annu. Rev. Pathol. Mech. Dis., 2006, vol. 1, no. 2, pp. 297–329.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) // JAMA. 2001. V. 285, № 12. P. 2486–2497.</mixed-citation><mixed-citation xml:lang="en">Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001, vol. 285, no. 12, pp. 2486–2497.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Василенко Ю.К., Лисевицкая Л.И., Фролова Л.М., Парфентьева Е.П., Скульте И.В., Василенко А.Ю., Кожарский В.В., Восканян В.Л. Гиполипидемические свойства тритерпеноидов // Хим.-фарм. журнал. 1982. Т. 45, № 5. С. 66–70.</mixed-citation><mixed-citation xml:lang="en">Vasilenko Yu.K., Lisevitskaya L.I., Frolova L.M., Parfentieva E.P., Skulte I.V., Vasilenko A.Yu., Kozharsky V.V., Voskanyan V.L. Chem.-Farm. J., 1982, vol. 45, no. 5, pp. 66–70 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shimoda H., Ninomiya K., Nishida N. et al. Anti-hyper-lipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action // Bioorg. Med. Chem. Lett. 2003. V. 13, № 2. P. 223–228.</mixed-citation><mixed-citation xml:lang="en">Shimoda H., Ninomiya K., Nishida N. et al. Anti-hyper-lipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action. Bioorg. Med. Chem. Lett., 2003, vol. 13, no. 2, pp. 223–228.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Eliza J., Daisy P., Ignacimuthu S., Duraipandiyan V. Anti-diabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.) Sm., in STZ-induced diabetic rats // Chem. Biol. Interact. 2009. V. 182, № 1. P. 67–72.</mixed-citation><mixed-citation xml:lang="en">Eliza J., Daisy P., Ignacimuthu S., Duraipandiyan V. Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.) Sm., in STZ-induced diabetic rats. Chem. Biol. Interact., 2009, vol. 182, no. 1, pp. 67–72.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kim S.H., Park K.S. Effects of Panax ginseng extract on lipid metabolism in humans // Pharmacol. Res. 2003. V. 48, № 5. P. 511–513.</mixed-citation><mixed-citation xml:lang="en">Kim S.H., Park K.S. Effects of Panax ginseng extract on li-pid metabolism in humans. Pharmacol. Res., 2003, vol. 48, no. 5, pp. 511–513.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hennekens C.H. Current perspectives on lipid lowering with statins to decrease risk of cardiovascular disease // Clin. Cardiol. 2001. V. 24, № 7. P. 2–5.</mixed-citation><mixed-citation xml:lang="en">Hennekens C.H. Current perspectives on lipid lowering with statins to decrease risk of cardiovascular disease. Clin. Cardiol., 2001, vol. 24, no. 7, pp. 2–5.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Кагарлицкий А.Д., Адекенов С.М., Куприянов А.Н. Сесквитерпеновые лактоны растений Центрального Казахстана. Алма-Ата: Наука, 1987. 240 с.</mixed-citation><mixed-citation xml:lang="en">Kagarlitskiy A.D., Adekenov S.M., Kupriyanov A.N. Seskviterpenovye laktony rasteniy Central'nogo Kazahstana</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по проведению доклинических исследований лекарственных средств. Ч. 1 / под ред. А.И. Миронова. М.: Гриф и К, 2013. 944 с.</mixed-citation><mixed-citation xml:lang="en">[Sesquiterpene lactones of plants in Central Kazakhstan]. Alma-Ata, Nauka Publ., 1987. 240 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sapronov N.S., Khnychenko L.K., Okunevich I.V., Gavrovskaya L.K. Potential antiatherosclerotic drugs: novel N-substituted taurinamide derivatives // Adv. Exp. Med. Biol. 2006. V. 583. P. 515–521.</mixed-citation><mixed-citation xml:lang="en">Rukovodstvo po provedeniyu doklinicheskih issledovaniy lekarstvennyh sredstv. Ch. 1. Ed. by A.I. Mironov [Guide-lines for pre-clinical trials of drugs. Part 1]. Moscow, Grif and Co Publ., 2013. 944 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bodor E.T., Offermanns S. Nicotinic acid: an old drug with a promising future // Br. J. Pharmacol. 2008. V. 153, № 1. P. 68–75.</mixed-citation><mixed-citation xml:lang="en">Sapronov N.S., Khnychenko L.K., Okunevich I.V., Gavrovskaya L.K. Potential antiatherosclerotic drugs: novel N-substituted taurinamide derivatives. Adv. Exp. Med. Biol., 2006, vol. 583, pp. 515–521.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ren N., Kaplan R., Hernandez M. et al. Phenolic acids sup-press adipocyte lypolisis via activation of the nicotinic acid receptor GRP109A (HM74a/PUMA-G) // J. Lipid Res. 2011. V. 50, № 5. P. 908–914.</mixed-citation><mixed-citation xml:lang="en">Bodor E.T., Offermanns S. Nicotinic acid: an old drug with a promising future. Br. J. Pharmacol., 2008, vol. 153, no. 1, pp. 68–75.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ren N., Kaplan R., Hernandez M. et al. Phenolic acids sup-press adipocyte lypolisis via activation of the nicotinic acid receptor GRP109A (HM74a/PUMA-G). J. Lipid Res., 2011, vol. 50, no. 5, pp. 908–914.</mixed-citation><mixed-citation xml:lang="en">Ren N., Kaplan R., Hernandez M. et al. Phenolic acids sup-press adipocyte lypolisis via activation of the nicotinic acid receptor GRP109A (HM74a/PUMA-G). J. Lipid Res., 2011, vol. 50, no. 5, pp. 908–914.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
